Migraine and the correlation between stroke: A systematic review and meta-analysis

Weiming Zhao,Dong Wang,Yujie Tan,Ji Yang,Shuning Zhang

DOI: https://doi.org/10.1097/md.0000000000040315

IF: 1.6

2024-11-13

Medicine

Abstract:Migraine is a common neurological disorder in clinical practice, characterized by recurrent attacks of chronic neurovascular disease. It is a common primary headache, typically presenting as unilateral or bilateral pain often accompanied by nausea, vomiting, and, in some typical cases, visual, sensory, and motor disturbances known as auras, with a potential family history. Recent epidemiological data shows that the incidence of migraine is approximately 15% to 25%, with an annual incidence of about 250 per 100,000 people, affecting approximately 1 billion individuals globally. [ 1 ] The Global Burden of Disease Study in 2016 identified migraine as one of the leading causes of disability worldwide. [ 2 ] About 90% of migraine patients experience their first attack before the age of 50, characterized by recurrent unilateral or bilateral moderate to severe pulsating headaches, often accompanied by photophobia or gastrointestinal symptoms. Additionally, neurological symptoms such as dizziness and cognitive impairment may also be present. [ 3 ] Studies estimate that the incidence of migraine in the United States is approximately 12%, while the global prevalence is higher, at about 14.4%, with 2.5% of episodic migraines progressing to chronic migraines. [ 4 ] Approximately one-third of migraine patients experience aura symptoms, including visual disturbances, sensory impairments, language or motor symptoms, with visual disturbances being the most common aura symptom. Migraines with aura are referred to as "migraine with aura," while those without are referred to as "migraine without aura."

medicine, general & internal